Chinese- REPORT SUMMARY
- TABLE OF CONTENTS
-
This report elaborates on the current development of the Neurodegenerative Drugs industry thoroughly based on the international market dynamics and China's market situation.
For a start, the report provides an in-depth analysis of the current market situation through three different aspects - by region, by type and by application, which includes market distribution of different types and applications, import and export analysis of major regions, development trends of different types of products in each region, market opportunities and market restrains of different applications.
Secondly, this report lists the major players in the industry, displaying their market positions and strengths and weaknesses of their products, picturing the current competitive situation of the whole market.
Last but not least, the report analyzes and predicts the investment prospects and risks in the industry on the basis of industry data, combined with experts' opinions and suggestions.
By Player:
UCB
Boehringer Ingelheim
Novartis
Sanofi
Biogen Idec
TEVA Pharmaceuticals
Merck Serono
Pfizer
By Type:
Selective Serotonin Reuptake Inhibitors
Dopamine Inhibitors
N Methyl D Aspartate
By Application:
Hospital
Research
By Research Region:
-
North China
-
Central China
-
South China
-
East China
-
Northeast China
-
Southwest China
-
Northwest China
TABLE OF CONTENT
Chapter 1 China Neurodegenerative Drugs Market Overview 2018-2029
-
1.1 China Neurodegenerative Drugs Industry Development Overview
-
1.2 China Neurodegenerative Drugs Industry Development History
-
1.3 China Neurodegenerative Drugs Industry Market Size (2018-2029)
-
1.4 China Neurodegenerative Drugs Market Analysis by Type from Production Side
-
1.4.1 China Neurodegenerative Drugs Production Volume, Production Value and Growth Rate of Selective Serotonin Reuptake Inhibitors (2018-2029)
-
1.4.2 China Neurodegenerative Drugs Production Volume, Production Value and Growth Rate of Dopamine Inhibitors (2018-2029)
-
1.4.3 China Neurodegenerative Drugs Production Volume, Production Value and Growth Rate of N Methyl D Aspartate (2018-2029)
-
1.5 China Neurodegenerative Drugs Market Analysis by Application from Consumption End
-
1.5.1 China Neurodegenerative Drugs Sales Volume, Sales Value and Growth Rate of Hospital (2018-2029)
-
1.5.2 China Neurodegenerative Drugs Sales Volume, Sales Value and Growth Rate of Research (2018-2029)
-
1.6 China Neurodegenerative Drugs Market Analysis by Region
-
1.6.1 North China Neurodegenerative Drugs Market Size and Growth Rate from 2018-2029
-
1.6.2 Central China Neurodegenerative Drugs Market Size and Growth Rate from 2018-2029
-
1.6.3 South China Neurodegenerative Drugs Market Size and Growth Rate from 2018-2029
-
1.6.4 East China Neurodegenerative Drugs Market Size and Growth Rate from 2018-2029
-
1.6.5 Northeast China Neurodegenerative Drugs Market Size and Growth Rate from 2018-2029
-
1.6.6 Southwest China Neurodegenerative Drugs Market Size and Growth Rate from 2018-2029
-
1.6.7 Northwest China Neurodegenerative Drugs Market Size and Growth Rate from 2018-2029
Chapter 2 China Neurodegenerative Drugs Industry Development Environment
-
2.1 Industry Development Environment Analysis
-
2.1.1 Industry Technological Progress Analysis
-
2.1.2 Industrial Organizational Innovation Analysis
-
2.1.3 Changes in Social Habits
-
2.1.4 Alterations in Government Policies
-
2.1.5 Impact of Economic Globalization
-
2.2 Domestic and Foreign Industry Competition Analysis
-
2.2.1 Comparative Analysis on Neurodegenerative Drugs Market Status and Competition at home and abroad in 2023
-
2.2.2 China Neurodegenerative Drugs Market Status and Competition Analysis in 2023
-
2.2.3 China Neurodegenerative Drugs Market Concentration Analysis in 2023
-
2.3 Problems and Countermeasures in the development of China Neurodegenerative Drugs Industry
-
2.3.1 Industry Development Constraints
-
2.3.2 Industry Development Considerations
-
2.3.3 Suggestions on Industry Development Measures
-
2.3.4 Development Strategies for SMEs
-
2.4 Influence of COVID-19 Outbreak on Neurodegenerative Drugs Industry Development
Chapter 3 Neurodegenerative DrugsIndustry Chain Analysis
-
3.1 Neurodegenerative Drugs Industry Chain
-
3.2 Neurodegenerative Drugs Upstream Industry Analysis
-
3.2.1 Upstream Industry Development Status
-
3.2.2 Upstream Industry Development Forecast
-
3.2.3 Impact of Upstream Industry on the Neurodegenerative Drugs Market
-
3.3 Neurodegenerative Drugs Downstream Industry Analysis
-
3.3.1 Downstream Industry Development Status
-
3.3.2 Downstream Industry Development Forecast
-
3.3.3 Impact of Downstream Industry on the Neurodegenerative Drugs Market
Chapter 4 China Neurodegenerative Drugs Market, by Type
-
4.1 China Neurodegenerative Drugs Market Trend, by Type
-
4.2 Product Types of Major Suppliers
-
4.3 Competitive Landscape of Major Types
-
4.4 China Neurodegenerative Drugs Total Production Volume and Growth Rate from Production Side
-
4.5 China Neurodegenerative Drugs Production Volume and Growth Rate, by Type
-
4.5.1 China Neurodegenerative Drugs Production Volume and Growth Rate of Selective Serotonin Reuptake Inhibitors
-
4.5.2 China Neurodegenerative Drugs Production Volume and Growth Rate of Dopamine Inhibitors
-
4.5.3 China Neurodegenerative Drugs Production Volume and Growth Rate of N Methyl D Aspartate
Chapter 5 China Neurodegenerative Drugs Market, by Application
-
5.1 Downstream Market Overview
-
5.2 Competitive Landscape of Major Applications
-
5.3 Market Potential Analysis, by Application
-
5.4 China Neurodegenerative Drugs Total Market Size and Growth Rate from Consumption End
-
5.5 China Neurodegenerative Drugs Market Size and Growth Rate, by Application
-
5.5.1 China Neurodegenerative Drugs Market Size and Growth Rate of Hospital
-
5.5.2 China Neurodegenerative Drugs Market Size and Growth Rate of Research
Chapter 6 China Neurodegenerative Drugs Market, by Region
-
6.1 China Neurodegenerative Drugs Production Volume and Production Value, by Region
-
6.2 China Neurodegenerative Drugs Sales Volume and Sales Value, by Region
Chapter 7 North China Neurodegenerative Drugs Market Analysis
-
7.1 North China Neurodegenerative Drugs Market, by Type
-
7.2 North China Neurodegenerative Drugs Market, by Application
Chapter 8 Central China Neurodegenerative Drugs Market Analysis
-
8.1 Central China Neurodegenerative Drugs Market, by Type
-
8.2 Central China Neurodegenerative Drugs Market, by Application
Chapter 9 South China Neurodegenerative Drugs Market Analysis
-
9.1 South China Neurodegenerative Drugs Market, by Type
-
9.2 South China Neurodegenerative Drugs Market, by Application
Chapter 10 East China Neurodegenerative Drugs Market Analysis
-
10.1 East China Neurodegenerative Drugs Market, by Type
-
10.2 East China Neurodegenerative Drugs Market, by Application
Chapter 11 Northeast China Neurodegenerative Drugs Market Analysis
-
11.1 Northeast China Neurodegenerative Drugs Market, by Type
-
11.2 Northeast China Neurodegenerative Drugs Market, by Application
Chapter 12 Southwest China Neurodegenerative Drugs Market Analysis
-
12.1 Southwest China Neurodegenerative Drugs Market, by Type
-
12.2 Southwest China Neurodegenerative Drugs Market, by Application
Chapter 13 Northwest China Neurodegenerative Drugs Market Analysis
-
13.1 Northwest China Neurodegenerative Drugs Market, by Type
-
13.2 Northwest China Neurodegenerative Drugs Market, by Application
Chapter 14 Company Profiles
-
14.1 UCB
-
14.1.1 UCB Company Profile
-
14.1.2 UCB Neurodegenerative Drugs Market Performance
-
14.1.3 Product&Service Introduction
-
14.2 Boehringer Ingelheim
-
14.2.1 Boehringer Ingelheim Company Profile
-
14.2.2 Boehringer Ingelheim Neurodegenerative Drugs Market Performance
-
14.2.3 Product&Service Introduction
-
14.3 Novartis
-
14.3.1 Novartis Company Profile
-
14.3.2 Novartis Neurodegenerative Drugs Market Performance
-
14.3.3 Product&Service Introduction
-
14.4 Sanofi
-
14.4.1 Sanofi Company Profile
-
14.4.2 Sanofi Neurodegenerative Drugs Market Performance
-
14.4.3 Product&Service Introduction
-
14.5 Biogen Idec
-
14.5.1 Biogen Idec Company Profile
-
14.5.2 Biogen Idec Neurodegenerative Drugs Market Performance
-
14.5.3 Product&Service Introduction
-
14.6 TEVA Pharmaceuticals
-
14.6.1 TEVA Pharmaceuticals Company Profile
-
14.6.2 TEVA Pharmaceuticals Neurodegenerative Drugs Market Performance
-
14.6.3 Product&Service Introduction
-
14.7 Merck Serono
-
14.7.1 Merck Serono Company Profile
-
14.7.2 Merck Serono Neurodegenerative Drugs Market Performance
-
14.7.3 Product&Service Introduction
-
14.8 Pfizer
-
14.8.1 Pfizer Company Profile
-
14.8.2 Pfizer Neurodegenerative Drugs Market Performance
-
14.8.3 Product&Service Introduction
Chapter 15 Research Conclusions and Investment Suggestions
-
15.1 Neurodegenerative Drugs Industry Research Conclusions
-
15.2 Neurodegenerative Drugs Industry Investment Suggestions
-
15.2.1 Suggestions on Industry Development Strategy
-
15.2.2 Suggestions on Industry Investment Direction
-
15.2.3 Suggestions on Industry Investment Strategy
List of Tables and Figures
-
Figure China Neurodegenerative Drugs Industry Market Size (2018-2029)
-
Figure China Neurodegenerative Drugs Production Volume, Production Value and Growth Rate of Selective Serotonin Reuptake Inhibitors (2018-2029)
-
Figure China Neurodegenerative Drugs Production Volume, Production Value and Growth Rate of Dopamine Inhibitors (2018-2029)
-
Figure China Neurodegenerative Drugs Production Volume, Production Value and Growth Rate of N Methyl D Aspartate (2018-2029)
-
Figure China Neurodegenerative Drugs Sales Volume, Sales Value and Growth Rate of Hospital (2018-2029)
-
Figure China Neurodegenerative Drugs Sales Volume, Sales Value and Growth Rate of Research (2018-2029)
-
Figure North China Neurodegenerative Drugs Market Size and Growth Rate from 2018-2029
-
Figure Central China Neurodegenerative Drugs Market Size and Growth Rate from 2018-2029
-
Figure South China Neurodegenerative Drugs Market Size and Growth Rate from 2018-2029
-
Figure East China Neurodegenerative Drugs Market Size and Growth Rate from 2018-2029
-
Figure Northeast China Neurodegenerative Drugs Market Size and Growth Rate from 2018-2029
-
Figure Southwest China Neurodegenerative Drugs Market Size and Growth Rate from 2018-2029
-
Figure Northwest China Neurodegenerative Drugs Market Size and Growth Rate from 2018-2029
-
Figure Neurodegenerative Drugs Industry Chain
-
Table Product Types of Major Suppliers in 2023
-
Figure China Neurodegenerative Drugs Market Share by Type in 2018
-
Figure China Neurodegenerative Drugs Market Share by Type in 2023
-
Figure China Neurodegenerative Drugs Total Production Volume and Growth Rate from Production Side (2018-2023)
-
Figure China Neurodegenerative Drugs Production Volume and Growth Rate of Selective Serotonin Reuptake Inhibitors (2018-2023)
-
Figure China Neurodegenerative Drugs Production Volume and Growth Rate of Dopamine Inhibitors (2018-2023)
-
Figure China Neurodegenerative Drugs Production Volume and Growth Rate of N Methyl D Aspartate (2018-2023)
-
Figure China Neurodegenerative Drugs Market Share by Application in 2018
-
Figure China Neurodegenerative Drugs Market Share by Application in 2023
-
Figure China Neurodegenerative Drugs Total Market Size and Growth Rate from Consumption End
-
Figure China Neurodegenerative Drugs Market Size and Growth Rate of Hospital (2018-2023)
-
Figure China Neurodegenerative Drugs Market Size and Growth Rate of Research (2018-2023)
-
Table China Neurodegenerative Drugs Production Volume by Region (2018-2023)
-
Table China Neurodegenerative Drugs Production Volume Share by Region (2018-2023)
-
Figure China Neurodegenerative Drugs Production Volume Share by Region (2018-2023)
-
Table China Neurodegenerative Drugs Production Value by Region (2018-2023)
-
Table China Neurodegenerative Drugs Production Value Share by Region (2018-2023)
-
Figure China Neurodegenerative Drugs Production Value Share by Region (2018-2023)
-
Table China Neurodegenerative Drugs Sales Volume by Region (2018-2023)
-
Table China Neurodegenerative Drugs Sales Volume Share by Region (2018-2023)
-
Figure China Neurodegenerative Drugs Sales Volume Share by Region (2018-2023)
-
Table China Neurodegenerative Drugs Sales Value by Region (2018-2023)
-
Table China Neurodegenerative Drugs Sales Value Share by Region (2018-2023)
-
Figure China Neurodegenerative Drugs Sales Value Share by Region (2018-2023)
-
Table North China Neurodegenerative Drugs Production Volume by Type (2018-2023)
-
Table North China Neurodegenerative Drugs Production Volume Share by Type (2018-2023)
-
Figure North China Neurodegenerative Drugs Production Volume Share by Type (2018-2023)
-
Table North China Neurodegenerative Drugs Sales Volume by Application (2018-2023)
-
Table North China Neurodegenerative Drugs Sales Volume Share by Application (2018-2023)
-
Figure North China Neurodegenerative Drugs Sales Volume Share by Application (2018-2023)
-
Table Central China Neurodegenerative Drugs Production Volume by Type (2018-2023)
-
Table Central China Neurodegenerative Drugs Production Volume Share by Type (2018-2023)
-
Figure Central China Neurodegenerative Drugs Production Volume Share by Type (2018-2023)
-
Table Central China Neurodegenerative Drugs Sales Volume by Application (2018-2023)
-
Table Central China Neurodegenerative Drugs Sales Volume Share by Application (2018-2023)
-
Figure Central China Neurodegenerative Drugs Sales Volume Share by Application (2018-2023)
-
Table South China Neurodegenerative Drugs Production Volume by Type (2018-2023)
-
Table South China Neurodegenerative Drugs Production Volume Share by Type (2018-2023)
-
Figure South China Neurodegenerative Drugs Production Volume Share by Type (2018-2023)
-
Table South China Neurodegenerative Drugs Sales Volume by Application (2018-2023)
-
Table South China Neurodegenerative Drugs Sales Volume Share by Application (2018-2023)
-
Figure South China Neurodegenerative Drugs Sales Volume Share by Application (2018-2023)
-
Table East China Neurodegenerative Drugs Production Volume by Type (2018-2023)
-
Table East China Neurodegenerative Drugs Production Volume Share by Type (2018-2023)
-
Figure East China Neurodegenerative Drugs Production Volume Share by Type (2018-2023)
-
Table East China Neurodegenerative Drugs Sales Volume by Application (2018-2023)
-
Table East China Neurodegenerative Drugs Sales Volume Share by Application (2018-2023)
-
Figure East China Neurodegenerative Drugs Sales Volume Share by Application (2018-2023)
-
Table Northeast China Neurodegenerative Drugs Production Volume by Type (2018-2023)
-
Table Northeast China Neurodegenerative Drugs Production Volume Share by Type (2018-2023)
-
Figure Northeast China Neurodegenerative Drugs Production Volume Share by Type (2018-2023)
-
Table Northeast China Neurodegenerative Drugs Sales Volume by Application (2018-2023)
-
Table Northeast China Neurodegenerative Drugs Sales Volume Share by Application (2018-2023)
-
Figure Northeast China Neurodegenerative Drugs Sales Volume Share by Application (2018-2023)
-
Table Southwest China Neurodegenerative Drugs Production Volume by Type (2018-2023)
-
Table Southwest China Neurodegenerative Drugs Production Volume Share by Type (2018-2023)
-
Figure Southwest China Neurodegenerative Drugs Production Volume Share by Type (2018-2023)
-
Table Southwest China Neurodegenerative Drugs Sales Volume by Application (2018-2023)
-
Table Southwest China Neurodegenerative Drugs Sales Volume Share by Application (2018-2023)
-
Figure Southwest China Neurodegenerative Drugs Sales Volume Share by Application (2018-2023)
-
Table Northwest China Neurodegenerative Drugs Production Volume by Type (2018-2023)
-
Table Northwest China Neurodegenerative Drugs Production Volume Share by Type (2018-2023)
-
Figure Northwest China Neurodegenerative Drugs Production Volume Share by Type (2018-2023)
-
Table Northwest China Neurodegenerative Drugs Sales Volume by Application (2018-2023)
-
Table Northwest China Neurodegenerative Drugs Sales Volume Share by Application (2018-2023)
-
Figure Northwest China Neurodegenerative Drugs Sales Volume Share by Application (2018-2023)
-
Table UCB Company Profile
-
Table UCB Neurodegenerative Drugs Revenue, Price and Gross (2018-2023)
-
Table Boehringer Ingelheim Company Profile
-
Table Boehringer Ingelheim Neurodegenerative Drugs Revenue, Price and Gross (2018-2023)
-
Table Novartis Company Profile
-
Table Novartis Neurodegenerative Drugs Revenue, Price and Gross (2018-2023)
-
Table Sanofi Company Profile
-
Table Sanofi Neurodegenerative Drugs Revenue, Price and Gross (2018-2023)
-
Table Biogen Idec Company Profile
-
Table Biogen Idec Neurodegenerative Drugs Revenue, Price and Gross (2018-2023)
-
Table TEVA Pharmaceuticals Company Profile
-
Table TEVA Pharmaceuticals Neurodegenerative Drugs Revenue, Price and Gross (2018-2023)
-
Table Merck Serono Company Profile
-
Table Merck Serono Neurodegenerative Drugs Revenue, Price and Gross (2018-2023)
-
Table Pfizer Company Profile
-
Table Pfizer Neurodegenerative Drugs Revenue, Price and Gross (2018-2023)
-
